News

Filter

Current filters:

Cardio-vascular

126 to 135 of 97213 results

Takeda partners with Monash University on gastrointestinal research

Takeda partners with Monash University on gastrointestinal research

10-12-2014

Japan’s largest drugmaker Takeda has entered into a research partnership with the Monash Institute…

AustraliaGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticals

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

10-12-2014

Ireland-headquartered drugmaker Shire has achieved positive results in a Phase III trial of guanfacine…

Guanfacine HydrochlorideIrelandNeurologicalPharmaceuticalResearchShire

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

Lundbeck and Otsuka present Phase III results of brexpiprazole in major depressive disorder

10-12-2014

Japanese drug maker Otsuka and Danish CNS specialist Lundbeck have announced Phase III study results…

brexpiprazoleLundbeckNeurologicalOtsukaPharmaceuticalResearchUSA

US Class Action law suit challenges pricing of Gilead's hepatitis-C drug Sovaldi

US Class Action law suit challenges pricing of Gilead's hepatitis-C drug Sovaldi

10-12-2014

US law firm Chimicles & Tikellis of Haverford, PA, has filed a law suit on behalf of the Southeastern…

Anti-viralsBiotechnologyGilead SciencesLawLegalPricingSocial IssuesSovaldiUnited StatesUSA

Medical burden still heavy for Chinese

10-12-2014

Chinese medical reform fiscal measures have lined the pockets of hospitals and companies but not done…

ChinaFinancialHealthcarePharmaceutical

Medicines Australia welcomes new report on Australian pharma industry

Medicines Australia welcomes new report on Australian pharma industry

10-12-2014

A new report has found that the pharmaceutical and medical technology industries in Australia produce…

AustraliaFinancialMedicines AustraliaPharmaceuticalPharmaceuticals policy

FDA Focus: Life-threatening disease and the benefit-risk of treatment options

FDA Focus: Life-threatening disease and the benefit-risk of treatment options

10-12-2014

In the fifth of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies…

ChemistryFDAPharmaceuticalRegulationUSA

126 to 135 of 97213 results

Back to top